Your browser doesn't support javascript.
loading
Patient Characteristics and Utilization Patterns of Short-Acting Recombinant Granulocyte Colony-Stimulating Factor (G-CSF) Biosimilars Compared to Their Reference Product.
Mendelsohn, Aaron B; Marshall, James; McDermott, Cara L; Pawloski, Pamala A; Brown, Jeffrey S; Lockhart, Catherine M.
Affiliation
  • Mendelsohn AB; Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, MA, USA.
  • Marshall J; Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, MA, USA.
  • McDermott CL; Biologics and Biosimilars Collective Intelligence Consortium (BBCIC), 675 North Washington Street, Suite 220, Alexandria, VA, USA.
  • Pawloski PA; HealthPartners Institute, Minneapolis, MN, USA.
  • Brown JS; Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, MA, USA.
  • Lockhart CM; Biologics and Biosimilars Collective Intelligence Consortium (BBCIC), 675 North Washington Street, Suite 220, Alexandria, VA, USA. clockhart@bbcic.org.
Drugs Real World Outcomes ; 8(2): 125-130, 2021 Jun.
Article in En | MEDLINE | ID: mdl-33517548
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Drugs Real World Outcomes Year: 2021 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Drugs Real World Outcomes Year: 2021 Type: Article Affiliation country: United States